Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.

Autor: Reardon MD; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom. Electronic address: mark.reardon@manchester.ac.uk., Bibby BAS; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom., Thiruthaneeswaran N; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia., Pereira RR; Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; Translational Oncogenomics, CRUK Manchester Institute and CRUK Manchester Centre, Manchester, United Kingdom., Mistry H; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom., More E; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom., Tsang Y; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada., Vickers AJ; Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom., Reeves KJ; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom., Henry A; Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, United Kingdom., Denley H; Department of Histopathology, Royal Shrewsbury Hospital, Shrewsbury & Telford NHS Trust, Shrewsbury, United Kingdom., Wylie J; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, Ohio., Hakansson A; Veracyte, Inc; San Diago; California., Ryu M; Veracyte, Inc; San Diago; California., Smith TAD; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; Nuclear Futures Institute, School of Computer Science and Engineering, Bangor University, Bangor, United Kingdom., Hoskin PJ; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom., Bristow R; Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; Translational Oncogenomics, CRUK Manchester Institute and CRUK Manchester Centre, Manchester, United Kingdom., Choudhury A; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom; The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom., West CML; Translational Radiobiology Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, United Kingdom.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Emergency cesarean section in pregnant trauma patients presenting after motor vehicle collision.

Autor: Hough M; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA., Nahmias J; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA., Santos J; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA., Swentek L; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA., Bristow R; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA., Butler J; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA., Grigorian A; University of California, Irvine, Department of Surgery, Division of Trauma, Burns and Surgical Critical Care, Orange, CA, USA.

Publikováno v: Heliyon [Heliyon] 2024 Sep 28; Vol. 10 (19), pp. e38707. Date of Electronic Publication: 2024 Sep 28 (Print Publication: 2024).

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.

Autor: Ci X; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Chen S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Present Address: West China School of Public Health, West China Fourth Hospital, and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, China., Zhu R; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Zarif M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Jain R; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Guo W; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Ramotar M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Gong L; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Xu W; MOE Key Laboratory of Metabolism and Molecular Medicine and Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, and Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China., Singh O; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mansouri S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Zadeh G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada., Wei GH; MOE Key Laboratory of Metabolism and Molecular Medicine and Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, and Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China., Xu W; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Bristow R; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Christie NHS Trust and CRUK Manchester Institute and Cancer Centre, Manchester, UK., Berlin A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. alejandro.berlin@rmp.uhn.ca., Koritzinsky M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. marianne.koritzinsky@uhnresearch.ca.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. marianne.koritzinsky@uhnresearch.ca.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. marianne.koritzinsky@uhnresearch.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. marianne.koritzinsky@uhnresearch.ca., van der Kwast T; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. theodorus.vanderkwast@uhn.ca.; Division of Anatomic Pathology, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. theodorus.vanderkwast@uhn.ca., He HH; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. hansenhe@uhnresearch.ca.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. hansenhe@uhnresearch.ca.

Publikováno v: BMC cancer [BMC Cancer] 2024 Jun 18; Vol. 24 (1), pp. 744. Date of Electronic Publication: 2024 Jun 18.

Medicolegal, infrastructural, and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?

Autor: Allanson E; Division of Obstetrics and Gynaecology, Medical School, The University of Western Australia, Perth, Western Australia, Australia., Hari A; Division of Gynecologic Oncology, University of California Irvine, Orange, California, USA., Ndaboine E; Department of Obstetrics & Gynecology, Catholic University of Health and Allied Sciences, Mwanza, Mwanza, Tanzania., Cohen PA; Division of Obstetrics and Gynaecology, Medical School, The University of Western Australia, Perth, Western Australia, Australia paul.cohen@uwa.edu.au., Bristow R; Division of Gynecologic Oncology, University of California Irvine, Orange, California, USA.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Mar 04; Vol. 34 (3), pp. 451-458. Date of Electronic Publication: 2024 Mar 04.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.